These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19072830)

  • 1. Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice.
    Bijl N; van Roomen CP; Triantis V; Sokolovic M; Ottenhoff R; Scheij S; van Eijk M; Boot RG; Aerts JM; Groen AK
    Hepatology; 2009 Feb; 49(2):637-45. PubMed ID: 19072830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
    Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
    Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glucosylceramide synthase inhibitor N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin induces sterol regulatory element-binding protein-regulated gene expression and cholesterol synthesis in HepG2 cells.
    Bijl N; Scheij S; Houten S; Boot RG; Groen AK; Aerts JM
    J Pharmacol Exp Ther; 2008 Sep; 326(3):849-55. PubMed ID: 18550691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
    Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
    Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.
    Aerts JM; Ottenhoff R; Powlson AS; Grefhorst A; van Eijk M; Dubbelhuis PF; Aten J; Kuipers F; Serlie MJ; Wennekes T; Sethi JK; O'Rahilly S; Overkleeft HS
    Diabetes; 2007 May; 56(5):1341-9. PubMed ID: 17287460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
    Shen C; Bullens D; Kasran A; Maerten P; Boon L; Aerts JM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
    Int Immunopharmacol; 2004 Jul; 4(7):939-51. PubMed ID: 15182733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism.
    Lombardo E; van Roomen CP; van Puijvelde GH; Ottenhoff R; van Eijk M; Aten J; Kuiper J; Overkleeft HS; Groen AK; Verhoeven AJ; Aerts JM; Bietrix F
    PLoS One; 2012; 7(10):e38520. PubMed ID: 23056165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic overexpression of caveolins increases bile salt secretion in mice.
    Moreno M; Molina H; Amigo L; Zanlungo S; Arrese M; Rigotti A; Miquel JF
    Hepatology; 2003 Dec; 38(6):1477-88. PubMed ID: 14647059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
    van Eijk M; Aten J; Bijl N; Ottenhoff R; van Roomen CP; Dubbelhuis PF; Seeman I; Ghauharali-van der Vlugt K; Overkleeft HS; Arbeeny C; Groen AK; Aerts JM
    PLoS One; 2009; 4(3):e4723. PubMed ID: 19305508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic glycosphingolipid deficiency and liver function in mice.
    Jennemann R; Rothermel U; Wang S; Sandhoff R; Kaden S; Out R; van Berkel TJ; Aerts JM; Ghauharali K; Sticht C; Gröne HJ
    Hepatology; 2010 May; 51(5):1799-809. PubMed ID: 20432257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
    Hall IH; Wong OT; Simlot R; Izydore RA
    Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1.
    Herrera Moro Chao D; Wang Y; Foppen E; Ottenhoff R; van Roomen C; Parlevliet ET; van Eijk M; Verhoek M; Boot R; Marques AR; Scheij S; Mirzaian M; Kooijman S; Jansen K; Wang D; Mergen C; Seeley RJ; Tschöp MH; Overkleeft H; Rensen PCN; Kalsbeek A; Aerts JMFG; Yi CX
    Diabetes; 2019 Dec; 68(12):2223-2234. PubMed ID: 31578192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
    Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
    Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of obesity and caloric intake on biliary lipid metabolism in man.
    Bennion LJ; Grundy SM
    J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion.
    Serhan N; Cabou C; Verdier C; Lichtenstein L; Malet N; Perret B; Laffargue M; Martinez LO
    Biochim Biophys Acta; 2013 Apr; 1831(4):719-25. PubMed ID: 23266391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
    Grundy SM
    J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.